Multiple Origins of Mutations in the mdr1 Gene—A Putative Marker of Chloroquine Resistance in P. vivax
Chloroquine combined with primaquine has been the recommended antimalarial treatment for Plasmodium vivax malaria infections for sixty years but the efficacy of this treatment regimen is threatened by chloroquine resistance. In this study we describe the prevalence of mutations in the P. vivax gene,...
Main Authors: | Schousboe, Mette L., Ranjitkar, Samir, Rajakaruna, Rupika S., Amerasinghe, Priyanie H., Morales, Francisco, Pearce, Richard, Ord, Rosalyn, Leslie, Toby, Rowland, Mark, Gadalla, Nahla B., Konradsen, Flemming, Bygbjerg, Ib C., Roper, Cally, Alifrangis, Michael |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634971/ |
Similar Items
-
Global and local genetic diversity at two microsatellite loci in Plasmodium vivax parasites from Asia, Africa and South America
by: Schousboe, Mette L, et al.
Published: (2014) -
Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka
by: Schousboe, Mette L, et al.
Published: (2007) -
Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal
by: Ranjitkar, Samir, et al.
Published: (2011) -
Maps of the Sri Lanka malaria situation preceding the tsunami and key aspects to be considered in the emergency phase and beyond
by: Briët, Olivier JT, et al.
Published: (2005) -
Genotyping Plasmodium vivax isolates from the 2011 outbreak in Greece
by: Spanakos, Gregory, et al.
Published: (2013)